Transplanting Hope brings hepatology, transplant medicine, addiction care, and behavioral health together around alcohol use disorder and liver transplantation. The Houston Methodist program examines candidate selection, psychosocial assessment, alcohol-associated hepatitis, and care before and after transplantation. It also considers relapse prevention, community treatment, the gut microbiome, emerging GLP-1 research, and questions surrounding the six-month abstinence rule. Held on March 20, 2026, at Houston Methodist Research Institute with virtual participation, the meeting includes clinical and ethical case discussions. It is relevant to transplant teams, hepatologists, addiction specialists, nurses, coordinators, and social workers involved in supporting patients through evaluation and long-term follow-up.
Learning Objectives
- Describe the pathophysiological mechanisms by which alcohol contributes to the development and progression of fatty liver disease, including its impact on lipid metabolism and inflammation.
- Explain the role of the intestinal microbiome in the etiology and maintenance of alcohol addiction, including how dysbiosis may influence gut-liver axis interactions and addiction pathways.
- Identify evidence-based criteria for selecting patients with alcohol use disorder as candidates for liver transplantation, including psychosocial, medical, and ethical considerations.
- Recognize key risk factors and characteristics associated with relapse in patients who have undergone liver transplantation for alcohol use disorder, such as behavioral patterns, genetic predispositions, and post-transplant support needs.
- Evaluate the overall impact of alcohol use disorder on liver transplantation outcomes and discuss strategies for multidisciplinary management, including prevention, monitoring, and integration of the program’s key topics into clinical practice.
- Evaluate emerging evidence on the role of GLP-1 agonists in the treatment of alcohol addiction, including their mechanisms of action, potential therapeutic applications, and implications for patients with alcohol use disorder undergoing liver transplantation.
- Recognize the role of liver transplantation in acute alcoholic hepatitis and the medical, surgical, and psychosocial evaluation required for optimal outcome and survival.
The original live activity listed 6.50 credits or contact hours across AMA, ABS MOC, nursing, social work, and transplant coordinator categories. These do not accompany store files. The retained topics describe educational scope and do not independently verify every recording in the package.
Topics
-
Emotional Intelligence and Managing a Transplant Program
-
Managing Individuals with AUD and Addiction
-
Alcohol-Associated Hepatitis and Liver Transplantation
-
3 Questions – Managing a Transplant Medical Review Board
-
Effects of Alcohol on Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
-
Intestinal Microbiome and Addiction
-
Panel Discussion – Management of Patients with Alcoholic Liver Disease
-
Strategies to Reduce Alcohol Relapse After Liver Transplantation
-
Inpatient Management of Alcohol Use Disorder Post Transplant
-
Role of Alcohol and in Liver Cancer
-
Absolute Contraindications for Liver Transplant in ALD
-
Why Is There Reluctance to Drop the 6-Month Abstinence Rule for AUD Liver Transplant
-
Medical Management of AUD in ALD
-
GLP-1 Receptor Agonists and Addiction
-
Liver Transplantation for Alcohol-Association Liver Disease at Houston Methodist Hospital
-
Panel Discussion – Challenges of Evaluating and Treating Intubated Patients for Liver Transplants
-
Outpatient Community Based Treatment of Individuals with Alcohol Use Disorder and Addiction
-
Alcohol Use Disorder and Advanced Heart Failure
-
AUD and Kidney Transplantation
-
Panel Discussion – Case Studies on Ethical and Clinical Challenges of Liver Transplantation for Patients with Alcohol Use Disorder
Faculty
- R. Mark Ghobrial, MD
- Joseph Galati, MD
- Gene Im, MD
- David Victor, MD
- Eamonn Quigley, MD
- Gerald Scott Winder, MD
- Kerry Ewens, LCSW-S
- Sudha Kodali, MD
- Kavish Patidar, DO
- Victor Ankoma-Sey, MD
- Akhil Shenoy, MD
- Archana Sadhu, MD
- Ashton Connor, MD
- Kevin Johnson, LCDC
- Ashrith Guha, MD
- Peter Nguyen, MD
- John Ontiveros, LCSW-S
- Chuck Garcia
- George Joseph
- Gregory T. Everson, MD, FACP, FAGA, FAASLD, FAST



